Mid-term results of percutaneous ventricular septal defect closure with Amplatzer Duct Occluder-II in children

Abstract Aim The aim of this study was to share the mid-term results of percutaneous ventricular septal defect closure using Amplatzer Duct Occluder-II in children. Background Nowadays, percutaneous ventricular septal defect closure is accepted as an alternative to surgery, but so far no ideal device has been developed for this procedure. Methods In the study centre, between April, 2011 and October, 2016, the ventricular septal defect of 49 patients was closed percutaneously using the Amplatzer Duct Occluder-II device, and seven of them were <1 year old. Results The mean age of patients was 86.8±52.6 months. The mean weight of the patients was 24.3±16 kg. The mean diameter of the defect was 3.7±1.4 mm. Mean fluoroscopy time and total procedure time were 37±19.3 and 74.1±27 minutes, respectively. The types of ventricular septal defects were muscular in six patients, and were perimembranous in the rest of them. We did not face any major complications during the procedure, but one patient was admitted with a complete atrioventricular block in the 6th month of follow-up. The total follow-up period was 66 months. Conclusion To our knowledge, our study includes the largest series of paediatric patients whose ventricular septal defect was closed using Amplatzer Duct Occluder-II percutaneously. When the complications during the 66-month follow-up period are taken into consideration, we can state that Amplatzer Duct Occluder-II is a safe and effective device, even in infants aged <1 year.

[1]  C. Manjunath,et al.  Treatment of congenital non‐ductal shunt lesions with the amplatzer duct occluder II , 2017, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[2]  M. Kaushik,et al.  Comparison of percutaneous device closure versus surgical closure of peri‐membranous ventricular septal defects: A systematic review and meta‐analysis , 2015, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[3]  N. Narin,et al.  ADO II in Percutaneous VSD Closure in Pediatric Patients. , 2015, Journal of interventional cardiology.

[4]  P. Ewert,et al.  Follow-Up of Patients with Interventional Closure of Ventricular Septal Defects with Amplatzer Duct Occluder II , 2015, Pediatric Cardiology.

[5]  K. Cao,et al.  Risk factors and outcomes of post-procedure heart blocks after transcatheter device closure of perimembranous ventricular septal defect. , 2012, JACC. Cardiovascular interventions.

[6]  H. Mugishima,et al.  The follow-up evaluation of electrocardiogram and arrhythmias in children with fulminant myocarditis. , 2011, Circulation journal : official journal of the Japanese Circulation Society.

[7]  C. Fraser,et al.  Current expectations for surgical repair of isolated ventricular septal defects. , 2010, The Annals of thoracic surgery.

[8]  İ. Erdoğan,et al.  Device closure of congenital ventricular septal defects with Amplatzer devices: first experiences in Turkey. , 2008, The Turkish journal of pediatrics.

[9]  G. Taylor,et al.  Pediatric Myocarditis: Emergency Department Clinical Findings and Diagnostic Evaluation , 2007, Pediatrics.

[10]  G. Fischer,et al.  The Amplatzer® Membranous VSD Occluder and the vulnerability of the atrioventricular conduction system , 2007, Cardiology in the Young.

[11]  R. Abella,et al.  Transcatheter closure of perimembranous ventricular septal defects: early and long-term results. , 2007, Journal of the American College of Cardiology.

[12]  R. Abella,et al.  Percutaneous closure of ventricular septal defects in children aged <12: early and mid-term results. , 2006, European heart journal.

[13]  Robert H. Anderson,et al.  Is complete heart block after surgical closure of ventricular septum defects still an issue? , 2006, The Annals of thoracic surgery.

[14]  Q. Cao,et al.  Transcatheter closure of perimembranous ventricular septal defects using the new Amplatzer membranous VSD occluder: results of the U.S. phase I trial. , 2006, Journal of the American College of Cardiology.

[15]  S. Pedra,et al.  Transcatheter closure of perimembranous ventricular septal defects. , 2004 .

[16]  M. Silka,et al.  The Clinical Course of Acquired Complete Heart Block in Children with Acute Myocarditis , 2003, Pediatric Cardiology.

[17]  M. O'Laughlin,et al.  Transcatheter occlusion of ventricular septal defect. , 1989, Catheterization and cardiovascular diagnosis.

[18]  J. F. Keane,et al.  Transcatheter closure of ventricular septal defects. , 1988, Circulation.